MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors
Crossref DOI link: https://doi.org/10.1007/s00520-020-05727-z
Published Online: 2020-09-04
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rapoport, Bernardo L.
Anderson, Ronald
Cooksley, Tim
Johnson, Douglas B.
Text and Data Mining valid from 2020-09-04
Version of Record valid from 2020-09-04
Article History
First Online: 4 September 2020
Free to read: This content has been made available to all.